NIPPON CHEMIPHAR CO.,LTD.

4539

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-07-31FY2027 Q1

Revenue

330.2100M JPY

YoY +0.6%

Operating Income

-2.6100M JPY

YoY -211.2%

Net Income

-1.2100M JPY

YoY -131.4%

EPS

-26.5JPY

YoY -142.0%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

330.9億円

246.9億円

163億円

79億円

-4.9億円

Rev: 325.1億円Op: 8.3億円NI: 7億円

Rev: 315.6億円Op: -2.4億円NI: 3.4億円

Rev: 307.5億円Op: -4.9億円NI: -1.8億円

Rev: 325.7億円Op: 6.1億円NI: 2.9億円

Rev: 330.9億円Op: 1.8億円NI: 2億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income0%

Revenue Progress81.800M

Revenue Forecast35000M

Net Income Progress-95M

Net Income Forecast60M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan